Voya Financial Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,649
Closed -$363K 593
2019
Q4
$363K Buy
7,649
+199
+3% +$8.94K 0.02% 464
2019
Q3
$342K Buy
7,450
+2,523
+51% +$117K 0.02% 457
2019
Q2
$252K Sell
4,927
-111
-2% -$6.51K 0.01% 531
2019
Q1
$349K Buy
5,038
+49
+1% +$3.29K 0.02% 447
2018
Q4
$295K Buy
4,989
+438
+10% +$37.8K 0.02% 433
2018
Q3
$524K Buy
4,551
+931
+26% +$105K 0.03% 345
2018
Q2
$454K Buy
3,620
+919
+34% +$112K 0.03% 341
2018
Q1
$281K Buy
2,701
+591
+28% +$65.4K 0.02% 442
2017
Q4
$229K Buy
+2,110
New +$211K 0.01% 497

Other funds holding CLB

Voya Financial Advisors's CLB Position: Q1 2020 in Review

Voya Financial Advisors sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 7,649 shares — an estimated $363K sold.

Voya Financial Advisors first reported a position in CLB in Q4 2017 and held it in 9 quarters. The position peaked at $524K in Q3 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Voya Financial Advisors reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Voya Financial Advisors sold 7,649 Core Laboratories shares in Q1 2020, an estimated $363K.
  • Voya Financial Advisors first reported a position in Core Laboratories in Q4 2017 and held it in 9 quarters.
  • Voya Financial Advisors's Core Laboratories position peaked at $524K in Q3 2018.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Voya Financial Advisors's 13F filing for Q1 2020, filed 15 May 2020.